Morbidity and Mortality Weekly Report: MMWR, Volume 33U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 1983 |
From inside the book
Results 6-10 of 100
Page 386
... Oreg . 95 67 Sacramento , Calif . 130 74 36 W.N. CENTRAL 660 434 134 43 23 Des Moines , Iowa 73 47 21 Duluth , Minn . Kansas City , Kans . Kansas City , Mo. 322 31 19 8 28 16 6 129 88 25 10 Lincoln , Nebr 33 23 8 Minneapolis , Minn 38 ...
... Oreg . 95 67 Sacramento , Calif . 130 74 36 W.N. CENTRAL 660 434 134 43 23 Des Moines , Iowa 73 47 21 Duluth , Minn . Kansas City , Kans . Kansas City , Mo. 322 31 19 8 28 16 6 129 88 25 10 Lincoln , Nebr 33 23 8 Minneapolis , Minn 38 ...
Page 403
... Oreg 3 Calif 476 Alaska Hawan 5 351612 98 7 60,355 68,004 130 81 3 4,131 5.197 4 4 3,589 3,533 23 4 93 50,126 56,176 102 72 15 1,501 1,685 2 1.008 1,413 1 3625 . 10 66 10 5.3188 47 Guam PR 33 VI כיאכ U 95 1.835 228 94 1,524 154 כי יכ U ...
... Oreg 3 Calif 476 Alaska Hawan 5 351612 98 7 60,355 68,004 130 81 3 4,131 5.197 4 4 3,589 3,533 23 4 93 50,126 56,176 102 72 15 1,501 1,685 2 1.008 1,413 1 3625 . 10 66 10 5.3188 47 Guam PR 33 VI כיאכ U 95 1.835 228 94 1,524 154 כי יכ U ...
Page 404
... Oreg 8 7 37 Calif 148 244 24 137 168 Alaska - 7 6INST 305 1 32 1 73 178 33 N 11 5 254 65 8315 45 5 128 215 8 1 8 6 13 31 5 123 194 1 5 Hawaii 3 4 139 3 1 1 14 69 13 Guam 1 P.R 3 VI Pac Trust Terr . כייכ U 83 U 2 2 81 13 5 U בי - כ 92 ...
... Oreg 8 7 37 Calif 148 244 24 137 168 Alaska - 7 6INST 305 1 32 1 73 178 33 N 11 5 254 65 8315 45 5 128 215 8 1 8 6 13 31 5 123 194 1 5 Hawaii 3 4 139 3 1 1 14 69 13 Guam 1 P.R 3 VI Pac Trust Terr . כייכ U 83 U 2 2 81 13 5 U בי - כ 92 ...
Page 405
... Oreg 70 60 Calif 2.104 2,696 3'12 2,134 2,330 2 Alaska 3 7 Hawaii 41 37 107 88 1,789 33 117 112 100 1,945 6'23 5 59 53 33 140 8--3-3 323 1 1 1 1 315 1 6 Guam P.R. 459 598 V.I 8 10 כייכ 5 4 217 263 2 1 33 ' 34 Pac . Trust Terr . U ...
... Oreg 70 60 Calif 2.104 2,696 3'12 2,134 2,330 2 Alaska 3 7 Hawaii 41 37 107 88 1,789 33 117 112 100 1,945 6'23 5 59 53 33 140 8--3-3 323 1 1 1 1 315 1 6 Guam P.R. 459 598 V.I 8 10 כייכ 5 4 217 263 2 1 33 ' 34 Pac . Trust Terr . U ...
Page 406
... Oreg 121 80 32 32825434 611 Sacramento , Calif . 151 101 28 11 WN CENTRAL 808 545 165 Des Moines , Iowa 91 66 13 Duluth , Minn . 39 29 Kansas City , Kans 33 19 Kansas City , Mo. 103 59 29 Lincoln , Nebr 35 28 Minneapolis , Minn 78 55 15 ...
... Oreg 121 80 32 32825434 611 Sacramento , Calif . 151 101 28 11 WN CENTRAL 808 545 165 Des Moines , Iowa 91 66 13 Duluth , Minn . 39 29 Kansas City , Kans 33 19 Kansas City , Mo. 103 59 29 Lincoln , Nebr 35 28 Minneapolis , Minn 78 55 15 ...
Other editions - View all
Common terms and phrases
Acquired Immunodeficiency Syndrome age group Alaska animal antibody Ariz Calif cancer Centers for Disease City Civilian clinical Colo Congenital rubella syndrome Conn cryptosporidiosis death Department of Health Disease Control E.S. CENTRAL Editorial Note Encephalitis Epidemiologic exposure Gonorrhea Guam Hawaii hemophilia Hepatitis hospital human illness immunization Immunodeficiency Syndrome AIDS increased infants infection influenza isolates Kans Legionellosis Leptospirosis lowa Malaria Mass measles MID ATLANTIC Minn MMWR Mortality Weekly Report Mumps Nebr NIOSH occurred Ohio Okla Oreg outbreak Pa.t Pac Trust Terr PACIFIC patients persons Pertussis Poliomyelitis population Primary & Secondary Psittacosis Public Health rabies Reporting Area risk RMSF Rubella specified notifiable diseases surveillance symptoms Syphilis Tenn tick-borne Total Toxic Shock syndrome Trichinosis Tuberculosis Tularemia Typhus fever U.S. Government Printing Unavailable TABLE United Upstate Utah vaccine Viral virus Wash weeks ending WN CENTRAL
Popular passages
Page 11 - National Center for Health Statistics. NCHS growth curves for children birth- 18 years. United States. Rockville, MD: National Center for Health Statistics. 1977. (Vital and health statistics. Series 1 1: Data from the National Health Survey, no.
Page 397 - Corticosteroids, other immunosuppressive agents, and immunosuppressive illnesses can interfere with the development of active immunity and predispose the patient to developing rabies. Immunosuppressive agents should not be administered during postexposure therapy, unless essential for the treatment of other conditions. When rabies post-exposure prophylaxis is administered to persons receiving steroids or other immunosuppressive therapy, it is especially important that serum be tested for rabies antibody...
Page 633 - ... authority to convey the warnings to the vaccinee, parent, guardian, or other responsible person of the possibility of vaccine-associated paralysis, particularly to susceptible family members and other close personal contacts. The Centers for Disease Control report that during 1972 to 1983, approximately 278.8 million OPV doses were distributed in the United States. During this same period, 87 vaccine-associated cases in apparently immunologically normal individuals were reported. Thirty-two occurred...
Page 397 - Two cases of neurologic illness resembling Guillain-Barre syndrome*'* a transient neuroparalytic illness, that resolved without sequelae in 12 weeks and a focal subacute central nervous system disorder temporally associated with HDCV, have been reported.
Page 437 - In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders, 1983:636-678.
Page 597 - Human cryptosporidiosis in immunocompetent and immunodeficient persons: studies of an outbreak and experimental transmission.
Page 397 - Once initiated, rabies prophylaxis should not be interrupted or discontinued because of local or mild systemic adverse reactions to rabies vaccine. Usually such reactions can be successfully managed with anti-inflammatory and antipyretic agents (eg aspirin). Reactions after vaccination with HDCV are less common than with previously available vaccines.
Page 398 - ... Category C. Animal reproduction studies have not been conducted with IMOVAX RABIES Vaccine. It is also not known whether the product can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Rabies vaccine should be given to a pregnant woman only if clearly needed. Because of the potential consequences of inadequately treated rabies exposure and limited data that indicate that fetal abnormalities have not been associated with rabies vaccination, pregnancy...
Page 557 - Hypertension detection and follow-up program cooperative group. Fiveyear findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
Page 392 - ... bite a person should be captured and observed for symptoms of rabies for 10 days. If symptoms do not develop, the animal may be assumed to be non-rabid. If the animal dies or is killed, its head, undamaged, should be sent promptly, under refrigeration but not frozen, to a public health laboratory. Any wild animal that bites or scratches a person should be killed at once and the head kept under refrigeration during transportation to a public health laboratory. Rubber gloves should be worn by the...